| Rank | Holder | SharesFloat % | Change | Date reported |
|---|---|---|---|---|
| 1 | T. Rowe Price Investment Management,Inc. | 10.30M (17.76%) | 6.01M Increased by +58.37% | Mar 31, 26 |
| 2 | FMR Inc | 9.26M (15.97%) | 1.04M Increased by +11.20% | Mar 31, 26 |
| 3 | VR Adviser, LLC | 8.49M (14.64%) | 0.00 Increased by 0.00% | Mar 31, 26 |
| 4 | Wellington Management Company LLP | 4.38M (7.54%) | -370.88K Decreased by -8.48% | Mar 31, 26 |
| 5 | BlackRock Inc | 4.09M (7.04%) | 301.66K Increased by +7.38% | Mar 31, 26 |
| 6 | Vanguard Group Inc | 2.86M (4.93%) | 612.19K Increased by +21.42% | Dec 31, 25 |
| 7 | RTW INVESTMENTS, LLC | 2.78M (4.80%) | 70.00K Increased by +2.52% | Mar 31, 26 |
| 8 | Vanguard Capital Management, LLC | 2.50M (4.31%) | 2.50M Increased by +100.00% | Mar 31, 26 |
| 9 | HHG PLC | 2.36M (4.07%) | 297.99K Increased by +12.62% | Mar 31, 26 |
| 10 | State Street Corp | 2.16M (3.73%) | 472.78K Increased by +21.86% | Mar 31, 26 |
| 11 | Driehaus Capital Management LLC | 1.92M (3.31%) | -262.90K Decreased by -13.69% | Mar 31, 26 |
| 12 | Perceptive Advisors LLC | 1.54M (2.66%) | -790.27K Decreased by -51.30% | Mar 31, 26 |
| 13 | Paradigm Biocapital Advisors LP | 1.35M (2.32%) | 225.00K Increased by +16.69% | Mar 31, 26 |
| 14 | Affinity Asset Advisors, LLC | 1.28M (2.22%) | 50.00K Increased by +3.89% | Mar 31, 26 |
| 15 | Geode Capital Management, LLC | 1.22M (2.10%) | 158.20K Increased by +13.00% | Mar 31, 26 |
| 16 | UBS Group AG | 1.14M (1.97%) | 169.50K Increased by +14.81% | Mar 31, 26 |
| 17 | T. Rowe Price Associates, Inc. | 1.14M (1.97%) | -93.98K Decreased by -8.22% | Mar 31, 26 |
| 18 | JPMorgan Chase & Co | 1.11M (1.91%) | -262.60K Decreased by -23.65% | Mar 31, 26 |
| 19 | Vestal Point Capital LP | 1.10M (1.90%) | 550.00K Increased by +50.00% | Mar 31, 26 |
| 20 | Frontier Capital Management CO Inc | 1.06M (1.84%) | 584.03K Increased by +54.87% | Mar 31, 26 |
| Rank | Holder | SharesFloat % | Change | Date reported |
|---|---|---|---|---|
| 1 | T. Rowe Price Capital Appreciation | 5.38M (9.27%) | 81.90K Increased by +1.52% | Apr 30, 26 |
| 2 | Fidelity Growth Compy Commingled Pl S | 2.58M (4.45%) | 1.75K Increased by +0.07% | Apr 30, 26 |
| 3 | Vanguard Health Care Inv | 1.91M (3.29%) | -162.42K Decreased by -8.51% | Mar 31, 26 |
| 4 | Vanguard Total Stock Mkt Idx Inv | 1.85M (3.18%) | 5.31K Increased by +0.29% | Apr 30, 26 |
| 5 | Fidelity Growth Company Fund | 1.84M (3.17%) | 12.10K Increased by +0.66% | Apr 30, 26 |
| 6 | State Street® SPDR® S&P® Biotech ETF | 1.26M (2.17%) | -7.72K Decreased by -0.62% | May 31, 26 |
| 7 | JNL/T. Rowe Price Capital Appreciation A | 1.13M (1.94%) | 854.55K Increased by +75.91% | Mar 31, 26 |
| 8 | iShares Russell 2000 ETF | 1.06M (1.84%) | 9.83K Increased by +0.92% | May 29, 26 |
| 9 | T. Rowe Price US Mid-Cap Growth Equity | 802.07K (1.38%) | 802.07K Increased by +100.00% | Mar 31, 26 |
| 10 | T. Rowe Price Mid-Cap Growth | 801.72K (1.38%) | -348.00 Decreased by -0.04% | Apr 30, 26 |
| 11 | T. Rowe Price Capital Apprec Eq ETF | 641.31K (1.11%) | -900.00 Decreased by -0.14% | May 30, 26 |
| 12 | Fidelity Blue Chip Growth | 621.36K (1.07%) | 7.62K Increased by +1.23% | Apr 30, 26 |
| 13 | Fidelity Blue Chip Growth Composite | 613.75K (1.06%) | 613.75K Increased by +100.00% | Mar 31, 26 |
| 14 | Vanguard Institutional Extnd Mkt Idx Tr | 607.30K (1.05%) | 6.75K Increased by +1.11% | Apr 30, 26 |
| 15 | Eventide Healthcare & Life Sciences I | 557.42K (0.96%) | 121.41K Increased by +21.78% | Mar 31, 26 |
| 16 | T. Rowe Price Health Sciences | 555.10K (0.96%) | 7.06K Increased by +1.27% | Mar 31, 26 |
| 17 | Fidelity Growth Company K6 | 545.14K (0.94%) | 1.75K Increased by +0.32% | Apr 30, 26 |
| 18 | VY® T. Rowe Price Capital Apprec S | 532.00K (0.92%) | 8.20K Increased by +1.54% | Apr 30, 26 |
| 19 | Vanguard Explorer Inv | 530.58K (0.91%) | 0.00 Increased by 0.00% | Mar 31, 26 |
| 20 | Fidelity Series Growth Company | 529.93K (0.91%) | 3.30K Increased by +0.62% | Apr 30, 26 |